Certara and The University of Manchester co-host inaugural model-based personalized drug dosing in healthcare conference
Clinical healthcare researchers, academic, and industry experts from eight countries collaborate to advance the goal of identifying the right drug dose for each patient.
Certara, in partnership with The University of Manchester, successfully organized the first-ever Health Care Summit on Model-based Precision Dosing on 19-20 May in the UK. Precision dosing is a key and proactive step toward achieving the goals of precision medicine, a global objective supported by world leaders, including President Obama under the Precision Medicine Initiative.
“Through its modeling and simulation work, Certara has been working toward the goal of precision dosing — providing the right drug dose to maximize therapeutic benefit, while reducing risk for each individual patient,” said Certara CEO Edmundo Muniz. “Through this Summit and the 15 examples which were presented that showcased the successful use of modeling and simulation in the hospital research environment, we are confident that precision dosing in healthcare will become mainstream shortly.”
Professor Kay Marshall, head of the Manchester Pharmacy School and a speaker at the conference, said: “Everyone is different and this means that they react to drugs in different ways. The emerging precision dosing field harnesses the explosion of genomic data and various markers of bodily functions using mathematical modeling to ensure that individuals get the best possible treatment.”
Speakers from eight countries, representing research institutions, academia, pharmaceutical companies, former regulators, and legal authorities spoke at the Summit. Sessions were organized around special populations representing the most fragile and complex population cohorts, including oncology, HIV, pediatric, obese, renally-impaired, cell transplant, and adolescent psychiatric patients and pregnant women. In addition to demonstrating how modeling and simulation facilitated individualized dosing, the conference focused on linking personalized dosing and its impact on public health.
Certara Chief Scientific Officer Amin Rostami, who also serves as the chair of systems pharmacology at The University of Manchester, said: “We now understand more fully the sources of variability, the individual characteristics of each patient, which can drive dosing decisions. The successful case studies shared at this Summit demonstrate that we are now ready to take the next step toward individualized dosing in everyday health care.”
Related News
-
News Pharmapack Awards 2024 Patient-Centric Design Award Winner – Dr Ferrer BioPharma
The 2024 Pharmapack Awards celebrated the best in innovation and design for the pharmaceutical packaging and drug delivery industry on January 24, 2024. -
News Women in Pharma: Minding the Gap at Pharmapack 2024
2024 marks the first year Pharmapack will host a Diversity track dedicated to bridging the gap within the pharmaceutical packaging and drug delivery sector. The track includes a panel discussion on 'Enabling Diversity in the Workplace,' focused... -
News Pharmapack Awards 2024 - Celebrating Packaging and Drug Delivery Innovation
The 2024 Pharmapack Innovation Awards ceremony celebrated the best in pharmaceutical packaging and drug delivery innovation at all levels. The awards were held on January 24, 2024 at the Paris Expo Porte de Versailles. -
News Pharmapack 2024 - From the Floor
Paris once again welcomes Europe’s leading trade show in pharmaceutical packaging and drug delivery innovation. Join our content team as Pharmapack 2024 opens its doors to leading experts and innovators in pharmaceutical packaging and drug delive... -
News CPHI Barcelona 2023: Partnering for Success – Managing Outsourcing Relationships to Optimise Manufacturing Operations
During CPHI Barcelona 2023, insightful content sessions offered attendees the chance to explore trending topics with expert speakers and panellists. Here, we summarise what the pharma industry and supply chain are talking about the most. -
News CPHI Barcelona 2023: Loading Potential – Artificial Intelligence for Pharma Manufacturing
During CPHI Barcelona 2023, insightful content sessions offered attendees the chance to explore trending topics with expert speakers and panellists. Here, we summarise what the pharma industry and supply chain are talking about the most. -
News Pharmaceutical industry supports COP28 health stance in joint statement
As COP28 takes place over this week in Dubai, UAE, several bodies in the pharmaceutical and health industries have come together to announce support of key movements in sustainability in the sector, and to recognise sustainability as a health issue.&nb... -
News CPHI Podcast Series: Start-ups take centre stage at CPHI Barcelona
The first episode of the CPHI Podcast Series since we attended CPHI Barcelona in October covers the Start-up market at the event, with expert Matthew Wise joining Editor Lucy Chard to discuss the event.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance